Proteomic analysis on N, N′-dinitrosopiperazine-mediated metastasis of nasopharyngeal carcinoma 6-10B cells

BMC Biochemistry

Volumn 13, Issue 1, 2012, Pages

  Li, Yuejin ^a   Liu, Na ^b   Huang, Damao ^b   Zhang, Zhenlin ^a   Peng, Zhengke ^a   Duan, Chaojun ^b   Tang, Xiaowei ^c   Tan, Gongjun ^a   Yan, Guangrong ^a   Mei, Wenhua ^a   Tang, Faqing ^a,b  

^a JINAN UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Carcinogen; Dinitrosopiperazine; Metastasis; Nasopharyngeal carcinoma; Quantitative proteomics

Indexed keywords

1,4 DINITROSOPIPERAZINE; AGR2 PROTEIN; AKR1B10 PROTEIN; CARCINOGEN; CASPASE 2; CATHEPSIN; CATHEPSIN B; CLUSTERIN; LACTATE DEHYDROGENASE; MITOCHONDRIAL PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CELL MOTILITY; CELL MOTION; CELL PROLIFERATION; DOWN REGULATION; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METASTASIS; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEOMICS; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOSKELETAL PROTEINS; HUMANS; ISOTOPE LABELING; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; NITROSAMINES; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEOME; TANDEM MASS SPECTROMETRY;

MUS MUSCULUS;

EID: 84869138847     PISSN: None     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-13-25     Document Type: Article

References (47)

1. Nasopharyngeal carcinoma. Wei WI, Sham JST, Lancet 2005 365 9476 2041 2054 10.1016/S0140-6736(05)66698-6 15950718
2. The prevalence and prevention of nasopharyngeal carcinoma in China. Cao SM, Simons MJ, Qian CN, Chin J Cancer 2011 30 2 114 119 10.5732/cjc.010.10377 21272443
3. Focus on nasopharyngeal carcinoma. Lo KW, To KF, Huang DP, Cancer Cell 2004 5 5 423 428 10.1016/S1535-6108(04)00119-9 15144950
4. Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Yu MC, Ho JH, Lai SH, Henderson BE, Cancer Res 1986 46 2 956 961 3940655
5. Traditional Cantonese diet and nasopharyngeal carcinoma risk: a large-scale case-control study in Guangdong. Jia WH, Luo XY, Feng BJ, Ruan HL, Bei JX, Liu WS, Qin HD, Feng QS, Chen LZ, Yao SY, et al. China. BMC Cancer 2010 10 446 10.1186/1471-2407-10-446
6. Nasopharyngeal carcinoma as a paradigm of cancer genetics. Simons MJ, Chin J Cancer 2011 30 2 79 84 10.5732/cjc.010.10609 21272439
7. Volatile N-nitrosamines and their precursors in Chinese salted fish-a possible etological factor for NPC in china. Zou XN, Lu SH, Liu B, Int J Cancer 1994 59 2 155 158 10.1002/ijc.2910590202 7927911
8. Occurrence of volatile nitrosamines in food samples collected in three high-risk areas for nasopharyngeal carcinoma. Poirier S, Hubert A, de-The G, Ohshima H, Bourgade MC, Bartsch H, IARC Sci Publ 1987 84 415 419 3679412
9. Carcinogenic effects in rats of nitrosopiperazines administered intravesically: possible implications for the use of piperazine. Lijinsky W, Kovatch RM, Cancer Lett 1993 74 1-2 101 103 8287362
10. Nitrosamine and related food intake and gastric and oesophageal cancer risk: a systematic review of the epidemiological evidence. Jakszyn P, Gonzalez CA, World journal of gastroenterology: WJG 2006 12 27 4296 4303 16865769
11. Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China. Yuan JM, Wang XL, Xiang YB, Gao YT, Ross RK, Yu MC, Int J Cancer 2000 85 3 358 363 10.1002/(SICI)1097-0215(20000201)85:3<358::AID- IJC11>3.0.CO;2-E 10652427
12. Adulthood consumption of preserved and nonpreserved vegetables and the risk of nasopharyngeal carcinoma: a systematic review. Gallicchio L, Matanoski G, Tao XG, Chen L, Lam TK, Boyd K, Robinson KA, Balick L, Mickelson S, Caulfield LE, et al. Int J Cancer 2006 119 5 1125 1135 10.1002/ijc.21946 16570274
13. Carcinoma of the nasal and paranasal regions in rats fed Cantonese salted marine fish. Huang DP, Ho JH, Saw D, Teoh TB, IARC Sci Publ 1978 20 315 328 730197
14. Induction of malignant nasal cavity tumours in Wistar rats fed Chinese salted fish. Yu MC, Nichols PW, Zou XN, Estes J, Henderson BE, Br J Cancer 1989 60 2 198 201 10.1038/bjc.1989.250 2765365
15. Induction of nasal and nasopharyngeal tumours in Sprague-Dawley rats fed with Chinese salted fish. Zheng X, Luo Y, Christensson B, Drettner B, Acta Otolaryngol 1994 114 1 98 104 10.3109/00016489409126024 7510449
16. [Profile of telomerase and telomerase RNA expression in nasopharyngeal carcinogenesis of rats induced by N, N'dinitrosopiperazine (DNP)]. Tang F, Jiang H, Duan Z, Chen B, Jing Z, Wu S, Zhonghua Bing Li Xue Za Zhi 2001 30 2 125 128 11866969
17. HSP70 and mucin 5B: novel protein targets of N, N'-dinitrosopiperazine- induced nasopharyngeal tumorigenesis. Tang FQ, Duan CJ, Huang DM, Wang WW, Xie CL, Meng JJ, Wang L, Jiang HY, Feng DY, Wu SH, et al. Cancer Sci 2009 100 2 216 224 10.1111/j.1349-7006.2008.01028.x 19068094
18. N, N'-Dinitrosopiperazine-mediated Ezrin Protein Phosphorylation via Activation of Rho Kinase and Protein Kinase C Is Involved in Metastasis of Nasopharyngeal Carcinoma 6-10B Cells. Tang F, Zou F, Peng Z, Huang D, Wu Y, Chen Y, Duan C, Cao Y, Mei W, Tang X, et al. J Biol Chem 2011 286 42 36956 36967 10.1074/jbc.M111.259234 21878630
19. Identification of differentially expressed genes in metastatic and non-metastatic nasopharyngeal carcinoma cells by suppression subtractive hybridization. Yang XY, Ren CP, Wang L, Li H, Jiang CJ, Zhang HB, Zhao M, Yao KT, Cell Oncol 2005 27 4 215 223 16308470
20. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Shevchenko A, Wilm M, Vorm O, Mann M, Anal Chem 1996 68 5 850 858 10.1021/ac950914h 8779443
21. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Olsen JV, de Godoy LM, Li G, Macek B, Mortensen P, Pesch R, Makarov A, Lange O, Horning S, Mann M, Mol Cell Proteomics 2005 4 12 2010 2021 10.1074/mcp.T500030-MCP200 16249172
22. A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics. Cox J, Matic I, Hilger M, Nagaraj N, Selbach M, Olsen JV, Mann M, Nat Protoc 2009 4 5 698 705 10.1038/nprot.2009.36 19373234
23. Global identification of miR-373-regulated genes in breast cancer by quantitative proteomics. Yan GR, Xu SH, Tan ZL, Liu L, He QY, Proteomics 2011 11 5 912 920 10.1002/pmic.201000539 21271679
24. Baicalein mediates inhibition of migration and invasiveness of skin carcinoma through Ezrin in A431 cells. Wu B, Li J, Huang D, Wang W, Chen Y, Liao Y, Tang X, Xie H, Tang F, BMC Cancer 2011 11 527 10.1186/1471-2407-11-527 22204275
25. AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D. Dumartin L, Whiteman HJ, Weeks ME, Hariharan D, Dmitrovic B, Iacobuzio-Donahue CA, Brentnall TA, Bronner MP, Feakins RM, Timms JF, et al. Cancer Res 2011 71 22 7091 7102 10.1158/0008-5472.CAN-11-1367 21948970
26. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. Kong QL, Hu LJ, Cao JY, Huang YJ, Xu LH, Liang Y, Xiong D, Guan S, Guo BH, Mai HQ, et al. PLoS Pathog 2010 6 6 1000940 10.1371/journal.ppat.1000940 20532215
27. Lack of oxidative phosphorylation and low mitochondrial membrane potential decrease susceptibility to apoptosis and do not modulate the protective effect of Bcl-x(L) in osteosarcoma cells. Dey R, Moraes CT, J Biol Chem 2000 275 10 7087 7094 10.1074/jbc.275.10.7087 10702275
28. Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. Amuthan G, Biswas G, Ananadatheerthavarada HK, Vijayasarathy C, Shephard HM, Avadhani NG, Oncogene 2002 21 51 7839 7849 10.1038/sj.onc.1205983 12420221
29. Oxidative stress in prostate cancer. Khandrika L, Kumar B, Koul S, Maroni P, Koul HK, Cancer Lett 2009 282 2 125 136 10.1016/j.canlet.2008.12.011 19185987
30. Palytoxins and cytoskeleton: An overview. Louzao MC, Ares IR, Cagide E, Espina B, Vilarino N, Alfonso A, Vieytes MR, Botana LM, Toxicon: official journal of the International Society on Toxinology 2011 57 3 460 469 10.1016/j.toxicon.2010.09.017
31. Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. Nomura T, Katunuma N, The journal of medical investigation: JMI 2005 52 1-2 1 9 15751268
32. Expression and clinical significance of cathepsin B and stefin A in laryngeal cancer. Li C, Chen L, Wang J, Zhang L, Tang P, Zhai S, Guo W, Yu N, Zhao L, Liu M, et al. Oncol Rep 2011 26 4 869 875 21667036
33. Cathepsin B may be a potential biomarker in cervical cancer. Wu D, Wang H, Li Z, Wang L, Zheng F, Jiang J, Gao Y, Zhong H, Huang Y, Suo Z, Histol Histopathol 2012 27 1 79 87 22127599
34. [Clinical significance of cathepsin B expressions in cervical cancer in tissues]. Nan fang yi ke da xue xue bao =. Wu D, Li ZN, Xu Y, Wang LH, Ding L, Wu JH, Huang Y, J South Med Univ 2010 30 6 1330 1332
35. Novel invasive orthotopic bladder cancer model with high cathepsin B activity resembling human bladder cancer. Lodillinsky C, Rodriguez V, Vauthay L, Sandes E, Casabe A, Eijan AM, J Urol 2009 182 2 749 755 10.1016/j.juro.2009.03. 076 19539312
36. Expression of cathepsin D and E-cadherin in primary laryngeal cancers correlation with neck lymph node involvement. Paksoy M, Hardal U, Caglar C, J Cancer Res Clin Oncol 2011 137 9 1371 1377 10.1007/s00432-011-1007-z 21789704
37. Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance. del Casar JM, Corte MD, Alvarez A, Garcia I, Bongera M, Gonzalez LO, Garcia-Muniz JL, Allende MT, Astudillo A, Vizoso FJ, J Cancer Res Clin Oncol 2008 134 2 153 161 17628829
38. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. Cheng AL, Huang WG, Chen ZC, Zhang PF, Li MY, Li F, Li JL, Li C, Yi H, Peng F, et al. J Proteome Res 2008 7 6 2415 2426 10.1021/pr7008548 18433155
39. Anterior gradient 2: a novel player in tumor cell biology. Brychtova V, Vojtesek B, Hrstka R, Cancer Lett 2011 304 1 1 7 10.1016/j.canlet.2010.12.023 21371820
40. Reactive carbonyls and oxidative stress: potential for therapeutic intervention. Ellis EM, Pharmacol Ther 2007 115 1 13 24 10.1016/j.pharmthera. 2007.03.015 17570531
41. Cadmium-induced up-regulation of aldo-keto reductase 1C3 expression in human nasal septum carcinoma RPMI-2650 cells: Involvement of reactive oxygen species and phosphatidylinositol 3-kinase/Akt. Lee YJ, Lee GJ, Baek BJ, Heo SH, Won SY, Im JH, Cho MK, Nam HS, Lee SH, Environ Toxicol Pharmacol 2011 31 3 469 478 10.1016/j.etap.2011.03.006 21787718
42. AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker. Ma J, Luo DX, Huang C, Shen Y, Bu Y, Markwell S, Gao J, Liu J, Zu X, Cao Z, et al. Int J Cancer 2012 131 6 862 E871 10.1002/ijc.27618 22539036
43. Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer. Wei L, Xue T, Wang J, Chen B, Lei Y, Huang Y, Wang H, Xin X, Int J Cancer 2009 125 4 791 806 10.1002/ijc.24316 19391138
44. Effects of clusterin over-expression on metastatic progression and therapy in breast cancer. Flanagan L, Whyte L, Chatterjee N, Tenniswood M, BMC Cancer 2010 10 107 10.1186/1471-2407-10-107 20307318
45. Overexpression of clusterin correlates with tumor progression, metastasis in gastric cancer: a study on tissue microarrays. Bi J, Guo AL, Lai YR, Li B, Zhong JM, Wu HQ, Xie Z, He YL, Lv ZL, Lau SH, et al. Neoplasma 2010 57 3 191 197 10.4149/neo-2010-03-191 20353268
46. Clusterin, a novel modulator of TGF-beta signaling, is involved in Smad2/3 stability. Lee KB, Jeon JH, Choi I, Kwon OY, Yu K, You KH, Biochem Biophys Res Commun 2008 366 4 905 909 10.1016/j.bbrc.2007.12.033 18082619
47. Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies. Lenferink AE, Cantin C, Nantel A, Wang E, Durocher Y, Banville M, Paul-Roc B, Marcil A, Wilson MR, O'Connor-McCourt MD, Oncogene 2010 29 6 831 844 10.1038/onc.2009.399 19935703